Your selections:
Achieving the World Health Organization's vision for clinical pharmacology
- Martin, Jennifer H., Henry, David, Gray, Jean, Day, Richard, Bochner, Felix, Ferro, Albert, Pirmohamed, Munir, Mörike, Klaus, Schwab, Matthias
An agenda for UK clinical pharmacology: An Australian perspective
Clinical pharmacology in research, teaching and health care
- Orme, Michael, Sjöqvist, Folke, Smith, Tony, Thuerman, Petra, Walubo, Andrew, Birkett, Donald, Brøsen, Kim, Cascorbi, Ingolf, Gustafsson, Lars L., Maxwell, Simon, Rago, Lembit, Rawlins, Michael, Reidenberg, Marcus
Complementary and alternative therapies in the palliative setting
- Martin, Jennifer H., Patel, Joanne
- Chin, Paul K. L., Charles, Kellie, Day, Richard, Schneider, Jennifer, Doogue, Matthew, Han, Catherine H., Herd, Sarah, Harrison, Claire, O'Mara, Deborah, Murnion, Bridin, McGuire, Treasure M., Hilmer, Sarah N., Martin, Jennifer, Reith, David, Joyce, David, Lucas, Catherine, Holford, Nick
Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience
- Lawson, John, O'Brien, Terry, Graham, Myfanwy, Renaud, Elianne, Jones, Dean, Freeman, Jeremy, Lawn, Nicholas, Martin, Jennifer H.
- Owens, Katie H., Medlicott, Natalie J., Zacharias, Matthew, Whyte, Ian M., Buckley, Nicholas A., Reith, David M.
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19
- Athavale, Akshay, Murnion, Bridin
Why maximum tolerated dose?
- Stampfer, Hans G., Gabb, Genevieve M., Dimmitt, Simon B.
Are you sure you would like to clear your session, including search history and login status?